# Selarsdi

NDC: 51759-708
Generic name: ustekinumab-aekn
Labeler / Manufacturer: Teva Pharmaceuticals USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20250312

FDA application: BLA761343

## Active ingredients

- USTEKINUMAB-AEKN: 130 mg/26mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51759-708"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51759-708
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=87f75b59-e48b-47c7-a4c0-5fe5965660e7